While Phytosulin is for people who may be resistant to insulin, DAOsin is for the treatment of histamine intolerance, an under-estimated and under-diagnosed condition which can lead to gastro-intestinal and circulation problems, migraine, asthma and allergy-like symptoms.
Richard Trevillion, CEO of Meldex, said: “These products have the potential to significantly improve the health and quality of life of many people. Their launches next year are in line with the company’s strategy of exploiting its newly established critical mass in valuable and growing markets.”